Vasiliki Liakouli

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Francesco Carubbi, Paola Cipriani, Alessandra Marrelli et al. · Arthritis Research & Therapy · 2013 · 178 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

Piero Ruscitti, Paola Cipriani, Francesco Masedu et al. · BMC Medicine · 2016 · 176 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

Piero Ruscitti, Francesco Masedu, Saverio Alvaro et al. · PLoS Medicine · 2019 · 133 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1<b>β</b>via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto et al. · Clinical & Experimental Immunology · 2015 · 131 citations · Full text

Veterinary Medicine, Cell Biology, Immunology +17

The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

Paola Cipriani, Paola Di Benedetto, Piero Ruscitti et al. · The Journal of Rheumatology · 2015 · 119 citations

Veterinary Medicine, Cell Biology, Pathobiology +17